Geneos Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.49K Hold
250
﹤0.01% 2227
2025
Q4
$3.6K Buy
+250
New +$3.76K ﹤0.01% 2220
2025
Q2
Sell
-2,494
Closed -$52K 3123
2025
Q1
$52K Buy
+2,494
New +$47.3K ﹤0.01% 1903
2024
Q4
Sell
-35,150
Closed -$689K 2890
2024
Q3
$689K Buy
35,150
+1,600
+5% +$31.8K 0.03% 482
2024
Q2
$658K Sell
33,550
-10,200
-23% -$194K 0.03% 434
2024
Q1
$788K Buy
43,750
+2,364
+6% +$42.9K 0.04% 395
2023
Q4
$701K Buy
41,386
+3,249
+9% +$64.6K 0.03% 396
2023
Q3
$757K Buy
38,137
+21,187
+125% +$401K 0.04% 371
2023
Q2
$318K Sell
16,950
-2,052
-11% -$41.4K 0.02% 573
2023
Q1
$388K Buy
19,002
+15,983
+529% +$322K 0.02% 494
2022
Q4
$64K Buy
+3,019
New +$62.6K ﹤0.01% 959

Other funds holding BTAL